Voyager Therapeutics (VYGR) EBIT Margin Growth (1y) (2016 - 2026)
Voyager Therapeutics (VYGR) EBIT Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Voyager Therapeutics |
222.52 Mn |
81.04 Mn |
- |
-63,364.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-63,364.00 |
| Dec 31, 2025 |
41,313.00 |
| Sep 30, 2025 |
-17,236.00 |
| Jun 30, 2025 |
-65,357.00 |
| Mar 31, 2025 |
-45,075.00 |
| Dec 31, 2024 |
-56,358.00 |
| Sep 30, 2024 |
58,551.00 |
| Jun 30, 2024 |
46,814.00 |
| Mar 31, 2024 |
-16,465.00 |
| Dec 31, 2023 |
-162,895.00 |
| Sep 30, 2023 |
-67,661.00 |
| Jun 30, 2023 |
220,119.00 |
| Mar 31, 2023 |
332,634.00 |
| Dec 31, 2022 |
156,440.00 |
| Sep 30, 2022 |
173,191.00 |
| Jun 30, 2022 |
-61,360.00 |
| Mar 31, 2022 |
-285,106.00 |
| Dec 31, 2021 |
38,331.00 |
| Sep 30, 2021 |
-176,849.00 |
| Jun 30, 2021 |
-207,517.00 |
